Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Johnson and Johnson

Generated: March 22, 2019

DrugPatentWatch Database Preview

SYMPAZAN Drug Profile

« Back to Dashboard

When do Sympazan patents expire, and when can generic versions of Sympazan launch?

Sympazan is a drug marketed by Aquestive Therap and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and nine patent family members in thirteen countries.

The generic ingredient in SYMPAZAN is clobazam. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the clobazam profile page.

Summary for SYMPAZAN
International Patents:109
US Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for SYMPAZAN
DailyMed Link:SYMPAZAN at DailyMed
Drug patent expirations by year for SYMPAZAN

US Patents and Regulatory Information for SYMPAZAN

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aquestive Therap SYMPAZAN clobazam FILM;ORAL 210833-001 Nov 1, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Aquestive Therap SYMPAZAN clobazam FILM;ORAL 210833-002 Nov 1, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Aquestive Therap SYMPAZAN clobazam FILM;ORAL 210833-001 Nov 1, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Chinese Patent Office
Julphar
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: